Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Background
The development of de novo diabetes mellitus is a serious complication of kidney …

Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients
transplanted in recent years. Background Post-transplant diabetes mellitus (PTDM) is a serious …

… COSIO FG, FALKENHAIN ME, PESAVENTO TE, HENRY ML, ELKHAMMAS EA, DAVIES
EA, BUMGARDNER GL, FERGUSON RM: Relationships between arterial hypertension and …

Background: Mycophenolate mofetil (MMF) has proven to be a very effective drug for the
prevention of acute rejection following renal transplantation when dosed as prescribed at 2 or 3 …

Introduction: Previous cross‐sectional analyses have identified significant associations
between quality of life (QOL), comorbidities and adverse effects in renal transplant recipients. …

Objective Herpes family viruses have been recognized as pathogens for many years in
immunosuppressed transplant or human immunodeficiency virus patients, but they have …

Background. FTY720, a novel immunomodulator, displays potent immunosuppressive
activity in a variety of preclinical transplant models. This study examined the safety, …

Background. There appears to be general consensus that a relationship exists between
noncompliance and clinical outcomes in health care, including renal transplantation. This study …

Objective: Cytomegalovirus (CMV) is a ubiquitous herpes virus that persists in the host in a
latent state following primary infection. We have recently observed that CMV reactivates in …

Renal transplant recipients have significantly higher mortality than individuals without kidney
disease and the excess mortality is mainly due to cardiovascular causes. In this study, we …